Tendencias21

Mayo Clinic: Drug induces morphologic, molecular and clinical remissions in myelofibrosis

Imetelstat, a novel telomerase inhibiting drug, has been found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis a Mayo Clinic study has found. The results were presented today at the 2013 American Society of Hematology Annual Meeting in New Orleans.

Fuente : http://www.eurekalert.org/pub_releases/2013-12/mc-…

RedacciónT21

RedacciónT21

Hacer un comentario